While converted forms of testosterone contribute to male pattern baldness, hair loss and high testosterone levels don’t really have much of a link. Some patients worry that increased levels of testosterone in the body can contribute to hair loss and male pattern baldness. No matter how it is administered, testosterone replacement therapy can benefit patients with low testosterone levels and will not directly cause hair loss or male pattern baldness.
The most significant risk factor for experiencing androgenetic alopecia is having a family history of the condition rather than the level of testosterone present in the body. When you consult with Dr. Green, she will assess your medical history, hair loss, and aesthetic goals to devise the best treatment option to help you grow thicker, denser hair. Whether your hair loss is accelerated by testosterone and DHT or caused by another factor, Dr. Green is here to help. Additionally, patients can undergo platelet-rich plasma (PRP) injections, a new and innovative treatment option used to improve tissue regeneration and healing and prevent hair loss.
Digestive sluggishness, acidity, and gut imbalance reduce how much nourishment actually reaches the hair root. Ayurveda looks beyond hormones alone. Dermatologists focus on identifying whether follicles are miniaturizing or temporarily shedding.
While age and genetics are the most recognised causes, several other factors can influence your hairline. One of the clearest signs is progression beyond the temples into the crown or overall thinning across the scalp. Thyroid disorders are another potential factor, as they can disrupt normal hair growth cycles. Hormonal imbalances can play a role, especially in conditions affecting testosterone or oestrogen levels.
This is greater than would be expected if pattern balding were a purely autosomal trait, and may suggest that there is an important paternal route of inheritance, either through a Y-chromosome gene or a paternal imprinting effect. This has been referred to as a "Hippocratic wreath" and rarely progresses to complete baldness. As it progresses, a rim of hair at the sides and rear of the head remains. With younger males, studies found metabolic syndrome to be at approximately a 4× increased frequency, which is deemed clinically significant. Both males aged 40–91 and younger male patients of early onset AGA (before the age of 35) had a higher likelihood of metabolic syndrome (MetS) and insulin resistance.